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Abstract 
 
EFFECT OF MORINGA OLEIFERA ON BONE DENSITY IN POST MENOPAUSAL 
WOMEN 
 
Jason Brown  
B.S., Furman University 
 
 
Chairperson:  Edward Merritt 
 
 
 Introduction: Osteoporosis is a clinical condition of low bone mineral density (BMD) that 
can lead to fractures with hip fractures accounting for more than 300,000 hospitalizations each 
year. The loss of ovarian estrogen after menopause plays a large role in why women are the most 
affected. Consuming foods that are rich in bone building vitamins and minerals may help provide 
important bone protection from this estrogen loss. Moringa Oleifera (M. Oleifera) is a tropical 
plant and contained in the leaves are nutrients such as beta-carotene, all of the essential amino 
acids, vitamin C, potassium, and calcium, and multiple important micronutrients that are critical 
for bone health. Therefore, the study objective is to determine the effects of M. Oleifera on the 
structure and function of bone in post-menopausal women ingesting 1g of M. Oleifera daily for 
12 weeks. Methods: Post-menopausal women (aged 60-70) were split into either the control 
(N=10) or experimental (N=10) group with each group consuming 1g daily of a cabbage placebo 
or M. Oleifera, respectively. No changes to daily habits including food or exercise were made and 
a three day diet log was recorded. DEXA scans were recorded on each individual before and after 
the intervention. The main focus was on the hip neck and total hip BMD and bone mineral 
content (BMC), as well as the whole body BMC and BMD. Results: No significant differences in 
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starting height (p=.107), weight (p=.547), body fat percentage (p=.620), or lean mass (p=.857) 
were observed between the groups. The only significant difference at the onset of the intervention 
was a higher right total hip BMD and BMC of the placebo group; this difference persisted 
throughout the intervention (p=.037). No significant interaction of the M. Oleifera on bone 
density was found with no difference in total body BMD between the two groups. Significant 
differences were found between pre-total body BMD and the post total body BMD with the 
average for the entire subject group dropping from a BMD of 1.046 g/cm² to 1.034 g/cm² 
(p=.030); which is a -1.11% drop. Amount of exercise and BMD also significantly correlated 
with the more exercise per week equally higher total body BMD (p=.044). Conclusion: Overall, 
no relationship between consuming M. Oleifera and an increase in bone density was found. This 
was mitigated by a lack of power that the study found. The -1.11% decrease in total body bone 
density is extremely high but could be explained by seasonal changes, medications taken, 
menopause age, and higher starting bone density. Future studies should look to continue this 
study for a longer period of time, take blood samples to measure hormone level changes, add 
exercise to examine its effect, increase the length of study. Developing novel ways to help 
prevent or slow osteoporosis and osteopenia can have a major impact on the well-being of 
millions of women.  
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Introduction 
 
Consuming a healthy and balanced diet is an important feature in daily life, as it helps 
improve overall health indices and can help reduce disease rates. Healthy diets that provide the 
recommended daily allowances of vitamins and minerals can help promote natural body growth 
and health. Currently, a majority of our country does not eat a healthy diet that contains the 
proper vitamins and minerals the body needs (Krebs-Smith, Guenther, Subar, Kirkpatrick, & 
Dodd, 2010). The United States, instead replaces 10% of daily calories with fast food and junk 
food. This excess of saturated fat, sugar, and sodium along with a low amount of necessary 
nutrients has shown to elicit negative health consequences such as increased obesity rates, disease 
rates, and medical costs (Center for Disease Control, 2013). One of those impacts has been on 
bone health. Millions of Americans suffer from low bone mass and this leads to millions suffering 
from secondary affects such as broken bones, decreased mobility, or even a loss or fear of 
completing daily activities (National Osteoporosis Foundation, 2002). These secondary affects 
can impact not only the single individual but the society as a whole by increased medical costs 
and a less productive work force. Consumption of the proper vitamins and minerals is imperative 
in order to prevent low bone density or other bone diseases. These preventative measures can help 
reduce future negative health and financial consequences for those directly involved and the 
society in general. 
 
Nutrition and Bone Health 
Consuming a healthy diet that contains adequate and proportional amounts of vitamins 
and minerals is extremely important in preventing bone disorders such as osteopenia and 
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osteoporosis (Nieves, 2005).  As stated earlier, the average American citizen currently does not 
meet the federal dietary recommendations, and over 90% intake more empty calories than are 
recommended  (Krebs-Smith et al., 2010).  Moreover, consumption of soda in the US has risen 
86% from 1970 to 1997 (Vartanian, Schwartz, & Brownell, 2007). The increase in these 
discretionary calories from soft drinks are currently replacing the intake of essential nutrients. In 
the long run, these negative dietary habits compromise bone density as the intake of colas (dark 
sodas) are found to cause lower bone mineral density (BMD) in older women, an observation 
attributed to high phosphoric acid content (Tucker et al., 2006). It appears that a diet that is low in 
important nutrients combined with excess discretionary calories from sodas and fast foods can 
cause negative health outcomes including bone health. Indeed, a study found that women that 
consumed dark vegetables have fewer fractures than women who do not but instead replace 
vegetables  with acid-forming fluids such as carbonated beverages (Lin et al., 2013).  
 The specific vitamins and nutrients in the diet associated with an increase in bone density 
later in life include calcium, vitamin D, magnesium, potassium, vitamin C, zinc, and fiber. (Gunn, 
Weber, McGill, & Kruger, 2015). Also, high consumption of fruit earlier in life positively 
correlates with high bone density in later life (New, Bolton-Smith, Grubb, & Reid, 1997). 
Further, another study that looked at the diet of women hospitalized with a hip fracture compared 
with healthy controls found that those with a higher-quality diet were less likely to suffer from a 
hip fracture. High-quality scores are typically characterized by a high consumption of plant-based 
foods (e.g., fruit, vegetables, and legumes), fish or white meat, whole grains, fiber, moderate 
alcohol intake, and a low consumption of red and processed meat. This type of diet is rich in 
antioxidants (e.g., vitamins A, C, and E, carotenes, zinc, and selenium), cations (magnesium, 
potassium, and calcium), vitamin K, folate, and polyunsaturated fatty acids (PUFA), and poor in 
saturated fatty acid (SFA) (Zeng et al., 2014). Going forward, future studies on bone density 
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should focus on examining the impact of a diet that is rich in fruits, vegetables, whole grains, and 
lean proteins on bone health. 
 
Bone Disease and Clinical Impacts 
Osteoporosis is a skeletal disorder characterized by compromised bone strength 
predisposing to an increased risk of fractures. Clinically, it is defined as being 2.5 standard 
deviations lower than the average bone density at any given age (Fonseca, Moreira-Goncalves, 
Coriolano, & Duarte, 2014). Osteopenia (an early state of osteoporosis) or osteoporosis increase 
the likelihood of fractures, which consequently may cause significant negative impacts on daily 
life (Dickinson, 2014). Hip fractures, which are one of the three main fractures associated with 
osteoporosis, are by far the most devastating, accounting for more than 300,000 hospitalizations 
every year. Collectively, these hip fractures are associated with chronic pain, increased 
dependence, reduced mobility, deformity, depression, loss of self-esteem, increased rates of 
hospitalization, and heavy personal socioeconomic burden (Dickinson, 2014).These effects not 
only impact the individual and those closest to them but they can also influence society as a 
whole. Economically, hip fractures are adding increased pressure to an already tight U.S. medical 
budget.  Hip fractures represent only a small portion of osteoporotic fractures (14%), but they 
account for as much as 72% of the cost expenditure of all fractures. This cost is projected to rise 
to over 18.2 billion dollars annually by 2025 (Burge et al., 2007). This amount of money equates 
to roughly $ 55 dollars per American per year. This increase in the medical costs of hip fractures 
is exacerbated by the fact that the demographic group of 50 year-olds in the U.S.is predicted to 
increase by 60% between 2000 and 2025, eventually reaching 121.3 million people (Burge et al., 
2007). Such a demographic increase in the population will inevitably lead to a corresponding 
increase in the percentage of people suffering from osteoporotic fractures, including hip fractures, 
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and subsequently, an upsurge in medical costs for individuals and the society at large. This trend 
signifies the importance of investing in and developing programs that target prevention of bone 
fracture and technologies that evaluate bone density as of the social and economic impact of these 
fractures continue to grow. 
The most common technology used for determining bone density is the dual-energy X-
ray absorptiometry (DEXA) (Provyn, Clarys, Wallace, Scafoglieri, & Reilly, 2008). This machine 
works by passing x-rays through the body with the densest bone letting the least amount of x-rays 
through. This equipment determines the variations in bone density with two different results. 
Bone mineral content (BMC) indicates the number of bone particles (in grams) in the scanned 
region, and bone mass density (BMD) which divides the scanned area by the BMC (how many 
particles are in the given region) and provides the data in g/cm2. The BMD is the most common 
representation of these scans and a normal or average BMD is 1.0. The DEXA can also provide 
the, z and t-score, body fat, and lean mass percentages in a few selected places such as the 
femoral head, lumbar spine, and total body (Provyn et al., 2008). These scans are one of the 
easiest and quickest measures of bone density and provide an accurate method for analyzing 
overall bone strength and have been shown to have quality accuracy for all measurements. 
 
Low Bone Density Factors 
Prevention of osteoporosis in females is imperative as they face the greatest danger given 
their longer life expectancy, smaller bone mass, and loss of the bone preserving action of estrogen 
(Greenway, Walkley, & Rich, 2012). Menopause, the permanent cessation of menses due to the 
loss of ovarian folliculo-genesis (The World Health Organization, 1995), which occurs on 
average around 51 years of age, with an age range varying between 40 and 60 years (Treloar, 
1981). One impact of menopause is the dramatic loss of the ovarian hormone, estrogen, an 
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important preserver of bone health. Estrogen works to help break apart osteoclasts, reduce 
inflammatory proteins that encourage osteoclastogensis, encourages osteoblast proliferation, and 
modulates the calcium levels in the blood. These effects of estrogen help maintain and encourage 
bone density throughout life (Khosla et al., 1998). 
As women age, serum estrogen will drop putting females at an especially high risk for 
fractures and bone diseases. Estrogen starts to decrease slightly as early as age thirty but is 
drastically reduced post-menopause (Finkelstein et al., 2013) and the loss of estrogen correlates to 
a slow loss of bone density even before menopause is reached (Khosla et al., 1998). Roughly, 8.2 
million women suffer from osteoporosis and an additional 27.3 million women having some form 
of low bone mass (Cosman et al., 2014). Therefore, the risk of suffering from a broken bone is 
extremely high for women. Most importantly though, after the age of 50, a woman is just as likely 
to die from a hip fracture as she is from breast cancer (Price, Langford, & Liporace, 2012). This 
clearly shows the importance of monitoring bone density and to encourage those at risk to partake 
in healthy bone-promoting activities.  
Due to the physiological roles of estrogen, other than the bisphosphonates discussed 
earlier, one of the most common ways to treat low bone density is with estrogen replacement 
therapies (ERT). Studies have shown the increase in bone density with ERT (Gambacciani & 
Levancini, 2014).  ERTs work to put estrogen back into circulation in the body which maintains 
the osteoclast/osteoblast ratio which will increase bone density (Gambacciani & Levancini, 
2014). The two main combinations of hormone replacement therapies are estrogen only and 
estrogen plus progestin, the latter of which is given for women who have not had a hysterectomy 
(Gynecologists, 2015). There are two main ways to distribute the ERT; locally or systemically. 
The ideal route for increasing bone density is systemic via a patch, pill, or gel. 
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However, like bisphosphonates, use of ERTs are limited due to the side effects shown 
with taking ERT. Exogenous estrogen only treatments thicken the uterine lining and increase the 
chance of uterine cancer. Combination treatments have been found to increase the risk of breast 
cancer, deep- vein thrombosis, heart attack, stroke, and gall bladder disease (Bae & Kim, 2015; 
Gambacciani & Levancini, 2014; Rahnama, Jastrzębska-Jamrogiewicz, Jamrogiewicz, & Trybek, 
2014; Zhao, Xu, & Zhao, 2015). For this reason, the 2015 European Code against Cancer 
currently recommends limiting or avoiding ERT use due to their link with cancers (Friis et al., 
2015). The cost/benefit analysis is one that needs to be looked at individually for each person by a 
trained physician. Women currently on ERT show low persistence or compliance with taking the 
drugs for the recommended time due to side effects. These results showed no difference in 
continuation of the therapy between the high or low dose group as well as with how the drugs 
were administered (oral versus cream) (Kyvernitakis et al., 2015). Overall, ERT have shown 
some beneficial responses to increasing bone density but there are quite a few risks associated 
with consuming these drugs. Developing an all-natural regimen for protecting and building bone 
mass could greatly reduce the prevalence of cancer in women by offering an alternative to ERT. 
One easy and safe way to improve bone density is to consume natural foods that contain 
necessary vitamins and minerals. Previous studies have shown the positive benefits to consuming 
healthy diets to improve bone density (Kim, Bu, Sung, & Choi, 2013; Macdonald, New, Golden, 
Campbell, & Reid, 2004; New et al., 1997; Palacios, 2006; Zeng et al., 2014). These diets have 
found relationships with specific vitamins and minerals such as potassium, magnesium, vitamin 
D, vitamin C, vitamin K, calcium, zinc, boron, and silicon. These articles show that a diet rich in 
these vitamins and minerals will help to improve bone density. One other article found that two 
main factors were associated with fracture rates: consuming nutrient dense food (fruits, 
vegetables, and whole grains), and consuming energy dense foods (soft drinks, potato chips, and 
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desserts). This article showed that the higher the nutrient dense diet the lower the fracture risk as 
well as the higher the energy dense diet the higher the fracture risk (Langsetmo et al., 2011). 
From these articles, it can be assumed that post-menopausal women that have low BMD or 
fractures also consume less of these nutrient rich foods, which shows the necessity for consuming 
these nutrients. 
 
Moringa Oleifera  
Moringa Oleifera (M. Oleifera) is a tropical plant native to northern India, Pakistan, the 
Himalayan region, Africa, Central America, and Arabia and is exceptionally rich in a variety of 
nutrients and medicinal phytochemicals. M. Oleifera contains various nutrients such as vitamin 
D, calcium, phosphorus, magnesium, and others that are associated with an increase in bone 
density (Palacios, 2006). M. Oleifera also contains micronutrients that play a critical role in bone 
health and in calcium absorption such as boron, vitamin C, magnesium, potassium, phosphorous 
and others (Issa, 2012; Price et al., 2012). For instance, boron stabilizes and extends the half-life 
of vitamin D (Ghanizadeh et al., 2012); magnesium (Mg) affects the activities of osteoblasts and 
osteoclasts, as well as bone homeostasis by modulating the concentration of parathormone and 
the activated form of vitamin D (McNaughton, Bolton-Smith, Mishra, Jugdaohsingh, & Powell, 
2005). Mg also contributes to bone structural development (Mahdavi-Roshan, Ebrahimi, & 
Ebrahimi, 2015); vitamin K reduces bone turn over, improves bone strength and plays an 
essential role in osteocalcin carboxylation (Bügel, 2008; Trumbo, Yates, Schlicker, & Poos, 
2001)) and vitamin C increases bone density and strength by increasing collagen formation and 
promotes healing during fracture (Leveille et al., 1997; Morton, 1991). Collectively, these 
micronutrients in M. Oleifera are expected to significantly impact bone health. 
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Despite the long history in use of the tree, information on the optimal dose of M. Oleifera 
needed to promote bone density in human is scanty.  There is however, useful information that 
can be gathered from animal and cell models. In one study, animals (rats, mice, and rabbits) were 
given 15 times more than the recommended daily dose of M. Oleifera leaf powder for adults, 
which is around suggested to be 1,600mg daily. The amount given was found to be equivalent to 
a child consuming 375 grams daily, and no adverse side effects were seen on any of the study 
animals (Boven & Morohashi, 2002; Stohs & Hartman, 2015). In another study that used mice, 
the dosage level of 30mg/kg per day was found to elicit a beneficial effect while no toxicities 
were seen at this dosage (Faizi et al., 1998). Another study using rats determined that there were 
no dangerous toxicity levels associated with M. Oleifera at or below 1,000 mg/kg, while 
supertoxicity levels were seen above 3,000 mg/kg (Asare et al., 2012). In recent human studies, 
supplementation levels of 500 mg/day in breastfeeding women (Estrella, Jacinto Bias III, David, 
& Taup, 2000) and up to 8000mg/day in men with broken jaws (Singh et al., 2011) were used, 
with no adverse effects seen in either study. 
Based on these earlier animal studies, a nutritional program that involves ingestion of a 
M. Oleifera powder could lead to increase bone strength post-menopausal women. More research 
is needed to determine if M. Oleifera can induce bone specific changes seen by an increase in 
bone mass density or bone mineral content. Given this knowledge, the purpose of this study is to 
determine the effects of M. Oleifera on the structure and function of bone in post-menopausal 
women ingesting 1 gram of M. Oleifera daily for 12 weeks seen with the use of the DEXA. 
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Statement of the Problem 
 
 
Proper nutrition has been proven to promote bone health, including development and 
growth. However, with age the bones begin decay and weaken, in part, due to loss of hormones 
such as estrogen. The loss of bone mass puts people, particularly women, at a greater risk for 
bone diseases such as osteoporosis and osteopenia. M. Oleifera is an edible plant that has been 
shown to be effective in exerting a variety of health benefits and has a variety of nutrients and 
minerals that might help slow bone mass loss. However, to date, no comprehensive human 
research study has examined the effects of M. Oleifera on bone mineral density. Therefore, the 
purpose of this study is to determine the effects of M. Oleifera on the structure and function of 
bone in post-menopausal women ingesting 1 gram of M. Oleifera daily for 12 weeks. 
 
 
 
Hypothesis 
 
I hypothesize that supplementation of M. Oleifera in the daily diet of postmenopausal 
women will promote bone mineral density and bone mineral content, within three months of 
intervention. 
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Significance of the Study 
 
 Due to the medical costs and risks associate with current treatments for low bone mass, it 
is imperative that alternative therapies that are affordable and safer are explored.  The present 
study investigates the effectiveness of using a whole leaf plant-based supplement used to improve 
the bone density score in postmenopausal women. This information will give doctors, 
nutritionists, and therapists the necessary information to discuss the possible benefits of M. 
Oleifera with their at-risk patients. 
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Review of Literature 
 
 
Proper nutrition is an important component of daily life, as it helps improve bone strength 
in young individuals and maintain bone strength in old individuals. In addition to either 
improving or maintaining bone strength, a proper diet containing a rich diversity in vitamins and 
minerals can provide a reduction in bone diseases and complications such as osteopenia and 
osteoporosis. Osteoporosis is defined as a skeletal disorder characterized by compromised bone 
strength predisposing to an increased risk of fractures, and is clinically defined as being 2.5 
standard deviations lower than the average bone density at any given age (Fonseca et al., 2014). 
Females, given their longer life expectancy, smaller bone mass, and loss of the bone preserving 
action of estrogen face the greatest danger to these diseases (Greenway et al., 2012). 
 One of the main clinical and economic consequences of osteoporosis is skeletal bone 
fracture with the most common breaks in weak parts of bones such as the wrist, spine, and hip 
(Department of Health & Human Services, 2004). Of the three main fractures, hip fractures are by 
far the most devastating, accounting for more than 300,000 hospitalizations every year. 
Collectively, these fractures are associated with chronic pain, increased dependence, reduced 
mobility, deformity, depression, loss of self-esteem, increased rates of hospitalization, and heavy 
personal socioeconomic burden (Dickinson, 2014). In the first year after hip fracture mortality 
rate increases 20-24% from all causes (Cooper, Atkinson, Jacobsen, O’Fallon, & Melton, 1993). 
More women than men have osteoporosis or osteopenia (low bone mass), particularly 
postmenopausal women, with roughly, 8.2 million women suffering from osteoporosis and an 
additional 27.3 million women having low bone mass (Cosman et al., 2014). After the age of 50 a 
woman is just as likely to die from a hip fracture as she is from breast cancer (Price et al., 2012). 
This increase in mortality rate is in part due to loss of ovarian estrogen, which plays a protective 
role on bone. These bone diseases, however, are controllable if not even preventable through an 
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increase in healthy eating, vitamin supplementation, and or exercise. Consumption of the proper 
nutrients daily, especially for older women, can drastically improve bone health and reduce the 
risk of fracture (Khosla et al., 1998). This review will discuss how and why bones become strong, 
the proper nutrition related to bone strength, and the effect M. Oleifera has on the body. 
  
Bone Strength Determinants 
The process of bone growth is dictated by involuntary factors such as genetics and 
hormone levels. Once humans have reached physical maturity, the bones continue to adapt and 
change for a variety of reasons including hormone and chemical levels.  Osteoblasts, osteocytes 
and osteoclasts are the three cell types involved in the development, growth and remodeling of 
bones. Osteoblasts are bone-forming cells, osteocytes are mature bone cells and osteoclasts are 
cells that break down and reabsorb bone (Carter, Van der Meulen, & Beaupre, 1996). As the body 
grows during childhood, the osteoblasts form new bone at the epiphyseal plate at the ends of the 
bone. Once maturity is reached the osteoblasts no longer increase the length of the bone but may 
still work by increasing the diameter of the bone which is called appositional growth (Carter et 
al., 1996). During adulthood, a person who is healthy and active will have osteoblasts that 
constantly create new bone while the osteoclasts remove old bone cells and make sure the bones 
do not become too bulky. This becomes an issue with age, however, as the osteoblast activity 
decreases and the osteoclast activity continues working at the same pace (Carter et al., 1996). 
This homeostatic process of bone formation and degradation is what many  osteoporotic drug 
therapies are working toward controlling (Burr, 1997). 
Bone strength determinants can be broken down into whole bone geometry, which is the 
bone size and cortical thickness, the microarchitecture, which is made up of cortical porosity, 
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trabecular connectivity, trabecular shape, and lastly, the tissue properties of the bone such as the 
collagen cross linking, cellular density, and osteocyte network (Fonseca et al., 2014).  
The first factors that influence bone development are individual genes. The genetic code 
dictates whether naturally thicker, stronger, or stunted bones will develop. These genetic factors 
are unchangeable and are just one factor dictating bone health. Besides the unchangeable genetic 
predispositions, there are a large number of hormonal and chemical changes that have a potent 
effect on bone strength. Sex hormone levels, specifically estrogen, have been found to be a large 
player in bone strength and health (Ducher et al., 2011). 17β-estradiol (E2; a form of estrogen), 
has been found to have a positive correlation with bone density in polycystic ovary syndrome 
patients (Katulski et al., 2014). The role of sex hormones was also found in men. A study using 
older Swedish men found that serum E2 and testosterone were inversely related, whereas serum 
sex hormone binding globulin was directly related to fracture risk. This study also reported that 
E2 was a much better independent predictor of bone loss than testosterone (Mellstrom et al., 
2008). These results show the importance of sex hormones and why increasing age is a large risk 
factor for decreased bone strength. 
This formation of bone requires a much longer amount of time for growth compared to 
the muscular system. Bone formation and degradation is a slow and continuous process that 
requires ample amounts of time in order to see significant differences in the body. A muscular 
system can see drastic changes in strength or muscle size within three to four weeks but bone 
growth takes more time in a growth environment for there to be changes. There are various 
studies that show this estimated time required for bone growth during exercise regimens. A 2014 
review article compares a large body of work that focuses on different training modalities and 
how those impact bone (Gregov & Šalaj, 2014). The studies included range from 10 weeks to 48 
months in duration and look at women, men, young and old participating in exercises from 
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vibration platforms to strength training to aerobic exercise (Gregov & Šalaj, 2014). These articles 
show that depending on the population and intensity of the intervention, significant increases in 
BMD can be seen in as little as ten to fourteen weeks (Guadalupe-Grau et al., 2009; Helge et al., 
2010; Johannsen, Binkley, Englert, Neiderauer, & Specker, 2003). Despite this possible 
intervention length the most common amount of time used for a bone strength intervention was 
around 6-10 months (Gregov & Šalaj, 2014).  
Other studies have examined the effect of nutritional interventions on bone density 
changes as well. One study studying elderly women (mean age 84.8 years) found that by 
increasing calcium and vitamin D fortified plain cheese, after 1.5 months, their PTH levels 
decreased, the insulin-like growth factor-1, osteocalcin, and type-1 procollagen levels increased 
(Bonjour et al., 2009). A reduction in PTH and increase in growth factor and osteocalcin are the 
first steps needed for bone growth to occur.  It was also shown that the bone turnover markers 
decreased after 1, 1.5, and 2 months of a dairy intervention in similar studies (Bonjour, Benoit, 
Payen, & Kraenzlin, 2013; Bonjour et al., 2009; Bonjour, Benoit, Rousseau, & Souberbielle, 
2012). Another study by Heaney et al. (1999) looked at an increase in calcium and vitamin D via 
an increase in dairy consumption in men and women aged 55-85 (Heaney et al., 1999). In 12 
weeks’ time this study found Mg and phosphorus increases along with reductions in PTH, and 
bone resorption marker, N-telopeptide excretion (Heaney et al., 1999). This study also 
demonstrates the shown precursor steps that precede bone stability. These articles show the speed 
at which one growth markers can be seen in the body after a nutritional supplementation. This 
gives a good timeline for the potential for positive bone changes within weeks or months rather 
than just years. 
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Dual Energy X-Ray Absorptiometry 
The standard for bone mass assessment is dual energy x-ray absorptiometry (DEXA) 
(Bareither, Grabiner, & Troy, 2008; Daly et al., 2008; Greenway et al., 2012; Kato et al., 2006; 
Nielson et al., 2011; Raghuvanshi & Singh, 2012; Shedd et al., 2007; Vainionpaa, Korpelainen, 
Leppaluoto, & Jamsa, 2005; Witzke & Snow, 2000; Zribi et al., 2014). DEXA is able to measure 
whole body bone mineral content and bone mineral density as well as BMD at a few specific sites 
including femoral head, lumbar spine, and hip region. This machine works by passing x-rays 
through the body with the densest bone letting the least amount of x-rays through. This process 
will then be able to show which areas of the bone are the densest by measuring areal bone mineral 
density. Areal bone mineral density is a two-dimensional representation of bone density as it 
reports the amount of bone mineral content (BMC) in a given area scanned. This BMC is the first 
important output from a DEXA. The second output from the DEXA is bone mass density (BMD), 
which is the area of the scanned region divided by the BMC (how many particles are in the given 
region) and gives the BMD in g/cm2. The BMD is the most common representation of these scans 
with a good or average BMD being at 1.0. The DEXA can also provide the, z and t-score, body 
fat, and lean mass percentages at a few select places such as the femoral head, lumbar spine, and 
total body.  
DEXA is the easiest and quickest measure of bone density and provides an accurate 
method for estimating overall bone strength (Vaccaro, Busetto, Bernardini, Anselmi, & Zotti, 
2012). When comparing the DEXA to other methods to determine BMD, it was found that the 
mean grey value was completely comparable to the DEXA (Vaccaro et al., 2012).Once the 
DEXA machine has been purchased, each scan, which will take around 8 minutes, is essentially 
free. The radiation given off during each scan is also very low, which allows for multiple scans to 
be completed at a time. A single DEXA scan produces 1 – 6 microseiverts (µSv) and a standard 
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flight from New York to Los Angeles generates 16 µSv; and daily radiation levels (at sea-level) 
expose us to 12 – 16 µSv. Overall, the DEXA provides an easy, quick, accurate, and well-studied 
depiction of BMD and BMC.  
 
Nutrition and Bone Health 
One modifiable factor contributing to bone health is the level of certain vitamins and 
minerals in the body. These vitamin and mineral levels are dependent on a wide variety diet 
including a large amount of fruits and vegetables. By increasing vegetable and fruit intake a 
group of midlife women were able to reduce their net endogenous acid production as well as 
increase the pH of their urine; which means the body was under less oxidative stress (Gunn et al., 
2015). Another article showed that the fragility fracture prevalence in participants who rarely or 
never consumed deep-colored vegetables was significantly higher than that of those who often 
consumed deep-colored vegetables: 17.6% versus 9.0% (Lin et al., 2013). In a study that only 
looked at the difference between animal and vegetable protein, the results showed that the animal 
protein group had a greater loss of bone than the vegetable group (Lanham-New, Lee, Torgerson, 
& Millward, 2007). One study that examined the roles of fruits on BMD found that daily increase 
of 100 g/1000 kcal fruit intake was associated with a 6.4% BMD increase in whole body, and 
4.8% in femoral neck in women (Liu et al., 2015). A longitudinal study that looked at diet records 
and bone density over a four year period found an increase in BMD with increased potassium and 
magnesium in three hip sites and one forearm site (Tucker et al., 1999). Secondly, an increase in 
BMD in two hip sites was found for women who consumed high amounts of fruits and 
vegetables.  
Beyond just fruit and vegetable intake two studies showed the affect overall meal quality 
can have on bone density. One study showed that higher quality diets that include fruits, 
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vegetables, whole grains, and lean proteins correlated to lower fracture rates in elderly women 
(Zeng et al., 2014). Again, another article focusing on nutrient dense versus energy dense found 
that eating higher nutrient dense meals produced a lower incidence toward fracture. At the same 
time eating higher energy dense meals produced a higher tendency toward fractures (Langsetmo 
et al., 2011). Fruits and vegetables provide a very high amount of proper nutrients for bone health 
versus processed and fatty foods. 
One very important nutrient for bone health is vitamin D. Vitamin D and its hormonal 
form, 1,25-dihydroxyvitamin D, elevate serum calcium and phosphorus levels necessary for bone 
mineralization. A 2010 study by The Osteoporotic Fractures in Men (MrOS) showed that serum 
vitamin D levels below 20ng/ml were associated with greater rates of hip bone loss and hip 
fracture (Cauley et al., 2010). This study was found to be inconsistent with other vitamin D 
studies including one by the same research group in 2012. The 2012 study proved that there was 
no association of fractures with lower BMD or BMC with abnormal Vitamin D levels (Barrett-
Connor et al., 2012; Roddam et al., 2007). One discrepancy between studies could be because the 
first study by Cauley et al. (2010) followed over 1600 men over a mean period of 5.3 years and 
sampled a larger proportion of non-Caucasian men, who consistently have lower vitamin D serum 
levels whereas the second study used mostly healthy, Caucasian, and non-obese individuals 
which are factors associated with higher vitamin D levels (Cauley et al., 2010). These differences 
between the two studies could be one reason as to why the association between vitamin D levels 
and bone health are inconsistent. Additionally, vitamin D levels seem to be closely linked to 
calcium levels. Studies have shown that when analyzed separate from calcium, there is no 
relationship between vitamin D supplementation and fracture risk (Avenell, Gillespie, Gillespie, 
& O’Connell, 2005). This is why most will recommend taking vitamin D and calcium together in 
order to facilitate the benefits of both. 
   
 
18 
 
Calcium, by itself, is also an important nutrient for bone health because it is the primary 
building block of bone. Blood calcium homeostasis is tightly controlled by maintaining the 
parathyroid and osteocalcin hormones. Calcium levels are held within a tight window between 9-
11mg/100ml of blood for normal homeostasis (Mundy & Guise, 1999). When this level becomes 
too low, the parathyroid gland will secrete PTH to break down bone to raise the level of calcium 
in the blood. Oppositely, when the calcium levels are too high in the blood the thyroid gland will 
secrete calcitonin to deposit excess calcium in the bones (Mundy & Guise, 1999). A regular and 
constant flux of PTH will slowly break down the bone, which can cause osteoporosis or 
osteopenia. This homeostatic control of calcium shows the importance of calcium in the diet. 
Another important element for bone growth is phosphorus. Hydroxyappatite, which is 
one of the primary mineral compounds in osseous tissue, is composed of calcium and phosphate. 
One study found significant increases in BMD at specific sites such as femoral neck and the 
lumbar spine with phosphorus supplementation. This article did not, however, find significant 
results when looking at whole body BMD (Lee, Kim, Kim, Seo, & Song, 2014) A second article 
found a 4.2% increase in BMC and a 2.1% increase in BMD (Lee & Cho, 2015). There are, 
however, negative side effects to consuming too much phosphorus intake as a too high 
concentration can throw off the calcium balance and cause no bone formation to occur. Therefore, 
the stated ratio should be around 0.60 of calcium to phosphorus (Lee & Cho, 2015). 
Other micronutrients also help play a role in bone development. For instance, boron 
stabilizes and extends the half-life of vitamin D (Ghanizadeh et al., 2012). Magnesium (Mg), with 
67% of total body Mg found in the skeletal system, affects the activities of osteoblasts and 
osteoclasts, as well as bone homeostasis by modulating the concentration of parathyroid hormone 
(PTH) and the activated form of vitamin D (Hayhoe, Lentjes, Luben, Khaw, & Welch, 2015; 
McNaughton et al., 2005). Mg also contributes to bone structural development (Department of 
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Health & Human Services, 2004). Vitamin K reduces bone turn over, improves bone strength and 
plays an essential role in osteocalcin carboxylation (Bügel, 2008). Vitamin C increases bone 
density and strength by increasing collagen formation and promoting healing during fracture 
(Leveille et al., 1997; Morton, 1991). Collectively, these micronutrients are expected to 
significantly impact bone health. 
Oppositely, one very important component of diets can severely impact bone health. The 
build-up of acid in the body can potentially have drastic bone health effects and needs to be 
monitored.  This production of acid in the body can occur when consuming foods that are high in 
acid (animal proteins/grains) and not ingesting foods high in bicarbonate (fruits and vegetables). 
This causes an increase in non-carbonic acid in the blood which will then combine with sulfur 
from the animal proteins to form sulfuric acid (Tabatabai et al., 2015). This will then form an 
increasing level of acid build-up in the system.  
 Renal function as well as some cardiorespiratory functions will help dispel this extra acid 
but renal function will decline as the body ages (Tabatabai et al., 2015). This will then cause a 
drop of pH in the body which the body will work to raise in order to maintain homeostasis. The 
bones serve as a constant base reservoir with large amounts of calcium salts (phosphates, 
carbonates, and hydroxides) constantly available. As the body continues to have a high acid 
content based on a diet without fruits and vegetables the bone will release basic calcium salts in 
order to counteract the acid levels. This results in a progressive drop in bone mass over time. 
Acidic fruits such lemons, oranges, and even yogurts could potentially increase an acid load in 
the system but this potential build-up is buffered by the magnesium and potassium found in these 
fruits as well (Liu et al., 2015). This acidic load can also be reduced by the calcium already in the 
fruit or in calcium fortified fruit beverages (Franklin, Masih, & Thomas, 2014). This leads to 
even acidic fruits and vegetables leading to a positive calcium balance. In order to reduce the 
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chance of chemical levels or acid problems becoming an issue it is important to ingest large 
amount of fruits and vegetables as well as limit unprocessed and fatty foods. 
 
Moringa Oleifera 
M. Oleifera is a tropical plant native to northern India, Pakistan, the Himalayan region, 
Africa, Central America and Arabia and is exceptionally rich in a variety of nutrients and 
medicinal phytochemicals. Specifically, it contains all the essential amino acids, beta-carotene, 
vitamin C, potassium, calcium, as well as other smaller micronutrients (Radek & Savage, 2008). 
M. Oleifera has comparable levels of calcium and protein to powdered milk, which is around 13 
mg/g of calcium (Lucey & Singh, 1997). More importantly, unlike pharmaceutical products or 
milk, which only contain one or two important elements essential for bone health, M. Oleifera 
contains multiple micronutrients that play a critical role in bone health and in calcium absorption, 
such as boron, vitamin C, magnesium, potassium, phosphorous and others (Issa, 2012; Price et 
al., 2012). 
The M. Oleifera plant has been widely used in its various forms including the seeds, 
leaves, oil, sap, bark, roots, and flowers. The leaves, however, are the most widely used due to 
their high nutritional content. The leaves are reported to have high antioxidant compounds 
including ascorbic acid, flavonoids, phenolics, and carotenoids (Alhakmani, Kumar, & Khan, 
2013; Vongsak, Sithisarn, & Gritsanapan, 2013). Various common uses are known for M. 
Oleifera including anti-inflammatory, antihypertensive, antioxidant, antidiabetic, anti-
hyperlipidemic, and cardio-protectant activities (Anwar, Latif, Ashraf, & Gilani, 2007; Mbikay, 
2012).  
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Nutritional Content 
Determining the exact macro and micro nutrients as well chemical components in M. 
Oleifera is important for future studies. One study on M. Oleifera has found that the dried leaves 
of M. Oleifera offer the most health benefits with roughly three to five times more vitamins and 
minerals in dried leaves versus the fresh leaves (Fuglie, 2002). The dried M. Oleifera leaves 
contain all of the essential amino acids with arginine (1,325mg), leucine (1,950mg), lysine 
(1,325mg), and phenylaline (1,388mg) accounting for the most abundant amino acids per 100g of 
edible portion (Fuglie, 2002). M. Oleifera dried leaves contained 2003mg of calcium per 100g of 
edible portion while milk only gives 120mg of calcium for the same dose and also contains up to 
25 times more iron than spinach, nine times the protein of yogurt, and ten times the vitamin A of 
carrots (Fuglie, 2002). 
Other studies have examined the properties found in M. Oleifera as well. Another study 
by Valdez-Solana et al. (2015) found that the most abundant macro-elements found in their 
analysis were calcium, magnesium, and potassium (Valdez-Solana et al., 2015). Also, in one of 
the batches of M. Oleifera they found similar protein amounts as Fugile et al. (2002), but in 
another batch they found much lower protein amounts, which they state is contrary to other 
studies. Furthermore, to explain the lack of protein found in one batch they cite it could be due to 
the specific geography or climate of the crop location (Valdez-Solana et al., 2015). Other 
researchers found that the protein content in M. Oleifera actually rivaled that of eggs (Fahey, 
2005). Overall, the nutritional content in M. Oleifera covers a wide breadth of vitamins, minerals, 
and vegetable based protein. This variety also gives potential evidence for increasing bone health 
as calcium, magnesium, potassium, vitamin A, iron, and protein are all included at high levels in 
M. Oleifera. 
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Human Studies 
 M. Oleifera has long been used as a traditional food source and medicine in the cultures 
where it grows naturally. The use of M. Oleifera in reported human studies, however, is limited. 
The majority of studies on M. Oleifera’s effects on humans have analyzed the anti-lipidemic and -
diabetic properties of M. Oleifera which has shown that M. Oleifera provides vast and substantial 
protective benefits (Arun Giridhari, Malathi, & Geetha, 2011; Kumar Gupta et al., 2013; Kumari, 
2010; Nambiar, Guin, Parnami, & Daniel, 2010; William, Lakshminarayanan, & Chegu, 1993). 
Other studies have explored the use of M. Oleifera on blood pressure and even milk lactation in 
postpartum women which also proved to be beneficial for both blood pressure and milk lactation 
(Estrella et al., 2000; Kushwaha, Chawla, & Kochhar, 2014). These studies highlight the potential 
benefits that M. Oleifera can offer to the human body. 
To date the authors have found only one study that examined the role of M. Oleifera on 
bone structure and function. M. Oleifera was given to study its effects on the healing process of 
mandibular fractures. The M. Oleifera intervention showed a decrease in swelling and tenderness 
and an increase in jaw mobility over the placebo group (Singh et al., 2011). Unfortunately, there 
were no x-ray scans administered to show any structural changes. Also, the exact amount of M. 
Oleifera prescribed was not listed in the article. There were no adverse effects found in any of the 
studies mentioned above. 
 
Animal/ In Vitro Studies 
 Even though few human studies have studied M. Oleifera there have been many that used 
animal and in vitro subjects. These studies have examined similar aspects as the human studies, 
looking at the antioxidant, antihypertensive, anti-hyperglycemic, and anti-dislipidemic properties 
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of M. Oleifera. The main difference between these studies comes from the way the M. Oleifera is 
administered. Most of the human studies use a leaf powder while the animal and in vitro studies 
mostly use a solubilized aqueous or alcohol solution. Overall, however, the results seem to be 
similar to human studies when analyzing the antioxidant, dislipidemic, cardioprotective, and anti-
cholesteric properties of M. Oleifera (Chumark et al., 2008; Jaiswal, Rai, Kumar, Mehta, & 
Watal, 2009; Jung, 2014; Nandave, Ojha, Joshi, Kumari, & Arya, 2009; Ndong, Uehara, 
Katsumata, & Suzuki, 2007; Panda, Kar, Sharma, & Sharma, 2013; Santos, Argolo, Paiva, & 
Coelho, 2012; Sasikala, Rooban, Priya, Sahasranamam, & Abraham, 2010; S Sreelatha, 
Jeyachitra, & Padma, 2011; Sreelatha & Padma, 2010; Tiloke, Phulukdaree, & Chuturgoon, 2013; 
Yassa & Tohamy, 2014).  
Only one animal model study has examined the efficacy of M. Oleifera on bone strength. 
This study completed by Nkuwana et al. (2014)  used a total of 2400 day old broiler chickens and 
divided them randomly into four different groups; control, starter (1-5 g of M. Oleifera/kg feed), 
grower (3-15 g/kg feed) and finisher (5-25g/kg feed) (Nkukwana, Muchenje, Masika, Hoffman, 
& Dzama, 2014). The researchers found that there was a significant positive relationship between 
the tibia weight, dried tibia weight, and the phosphorus content on the tibia compared to the 
amount of M. Oleifera in the feed. There was also a trend that associated higher calcium with the 
higher M. Oleifera concentrations. These results show that M. Oleifera was able to improve the 
tibia integrity and inorganic content of the broiler chickens (Nkukwana et al., 2014). 
 
Toxicity Levels 
 
The M. Oleifera tree has been consumed by the local communities in Africa and Asia as 
an important vegetable in their diet for thousands of years. Despite this long history, determining 
a set amount of M. Oleifera needed to see bone density benefits is unknown. However, useful 
information can be gathered from animal and cell models. In one study, animals (rats, mice, and 
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rabbits) were given 15 times the recommended daily dose of M. Oleifera leaf powder (800mg 
twice daily), which is equivalent to a child consuming 375 grams daily, and no adverse side 
effects were seen (Boven & Morohashi, 2002). In another study that used mice, the dosage level 
of 30mg/kg was found to elicit a beneficial effect while no toxicities were seen at this dosage 
(Faizi et al., 1998). Another study using rats showed that there were no dangerous toxicity levels 
associated with M. Oleifera at or below 1,000 mg/kg, while supratoxicity levels were seen above 
3,000 mg/kg (Asare et al., 2012). 
In more recent human studies, supplementation levels of 500 mg/day in breastfeeding 
women (Estrella et al., 2000) and up to 8000mg/day in men with broken jaws (Singh et al., 2011) 
were used, with no adverse effects seen in either study. Another study examined the effects of a 
one-time bolus of 5000mg of M. Oleifera and there were no adverse effects seen after this 
ingestion (William et al., 1993). Another study used 7000mg daily for 40 days without any 
problems indicated (Kumari, 2010). Therefore, the long history of this tree along with the animal, 
cell, and human models that are available indicate that at a dosage of 20mg/kg there should have 
no adverse effects on the subjects. 
 
Conclusion 
Osteoporosis and osteopenia are two bone diseases that can cause significant harm to 
females that have reached and surpassed menopause (Daan & Fauser, 2015). The importance of 
getting the proper nutrition is paramount for bone health. General nutrition such as eating more 
fruits and vegetables has been found to relate to positive bone effects (Gunn et al., 2015). More 
specifically, getting enough vitamin D along with calcium is associated with increases in bone 
density levels (Lips et al., 2010). M. Oleifera has been shown to contain all of these important 
vitamins and minerals (Fuglie, 2002). M. Oleifera also has shown to have various other beneficial 
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roles in general health such as antioxidant, anti-hypertensive, anti-cholesteric, and anti-
hyperlipidemic properties.  The previous studies show very positive benefits for overall health 
improvements but there is still a gap in the research that related to its benefits on bone structure 
and function. With bone density being of utmost importance to millions of older women in the 
US, it is imperative that more research is done on the bone density effects of M. Oleifera. 
Therefore, the purpose of this study is to determine the effects of M. Oleifera on the structure and 
function of bone in post-menopausal women ingesting 1 gram of M. Oleifera daily for 12 weeks. 
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Methodology 
 
Experimental Design 
Twenty four untrained post-menopausal women (60-70 years old) will be randomly 
assigned to either the control group (no program) or the experimental group (M. Oleifera 
supplement group). Both groups will ingest 1000mg each day (either M. Oleifera or a cabbage 
placebo) for 12 weeks. The bone scans will be conducted pre-supplementation and after 12 weeks 
to determine what adaptations the M. Oleifera will cause in the bone. The bone mass density, 
bone mineral content, and any anthropomorphic changes will be recorded to determine if there 
are any specific bone changes. 
The subjects’ first visit to the laboratory will serve as the information and testing session. 
The information session will consist of the informed consent document, health history and 
physical activity questionnaire. This first testing session will consist of the first DEXA scans. The 
participants will then be given six weeks’ worth of their supplement. The subjects will come back 
to the testing site again at six weeks to pick up their second half of the supplements and they will 
be instructed on how to fill out a three day diet log. The diet log will be analyzed and averaged 
through the USDA Super Tracker online program. The third and last visit will be 12 weeks after 
the start of supplementation and will consist of the second DEXA measurements as well as 
turning in the diet record that will determine normal diet nutrients as well as caffeine intake.  
 
Dual Energy X-Ray Absorptiometry (DEXA) Measurements. 
DEXA scanning allows for the measurement of whole body bone density as well as the 
specific density of the hip and femoral head. The subject will lay on the DEXA machine scanner 
motionless for 6-10 minutes while the scan is performed. This first scan will measure the whole 
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body bone density as well as the basic body composition. The subject will then be asked to lay 
motionless for another 6-10 minutes while another DEXA scan is completed, which will measure 
the bone density and characteristics of the hip and femoral head. The subject will lay with both 
hips abducted 15° while the whole legs are rotated inward 25°. This helps separate the femur and 
hips to get a clear scan of the hips. This will be aided by placing the feet on either side of a given 
foam plastic pyramid and strapped into place. The risks associated with a DEXA scan include 
exposure to small amounts of radiation. DEXA scanning utilizes radiation to obtain an image of 
the body. Everyone receives a small amount of unavoidable radiation from the environment each 
year. Some of this radiation comes from space and some from naturally-occurring forms of 
radioactive water and minerals. The DEXA scan technique gives the body the equivalent of about 
4 extra days’ worth of this natural radiation. The radiation received from the DEXA scan is only 
from the individual scan and does not include exposure received from other tests. The BMD, t-
score and z-scores of the whole body will be recorded as well as the BMD, t-score, and z-scores 
of the right and left total hip and femoral necks. These data points will be used for analysis to find 
if there were any significant differences between the two groups after the intervention period.  
 
M. Oleifera Supplementation 
The supplementation of the M. Oleifera will begin after the first visit which will contain 
the signing of consent, the pQCT scans, and the DEXA scans. Once the subject goes through 
these scans the subject will be randomly assigned to either the placebo group or the M. Oleifera 
group. The M. Oleifera group will be given whole leaf M. Oleifera powder in capsule form at 
1000mg/50kg daily for 12 weeks. M. Oleifera harvested and processed under optimal conditions 
will be weighed on a scale and packed into capsules under sterile conditions. Each capsule will 
contain 500 mg of M. Oleifera. Each participant, in the treatment group, regardless of their 
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weight, will take two capsules daily for 12 weeks. The subjects will be instructed to consume 
their capsules once daily orally. If they miss a day they should not double the dosage the next 
day. The control group will be given a placebo capsule consisting of cabbage, which has 
significantly lower levels of the vitamins and nutrients found in M. Oleifera, and subjects will 
take an equivalent dosage of the cabbage as the M. Oleifera supplement. The cabbage placebo 
will be packaged into one capsule containing the same 1000mg amount. The placebo group will 
be given the exact same instructions for consumption as the M. Oleifera group, and the study will 
be conducted in a double blind manner. The dietary records will be collected and analyzed to 
determine any significant differences between the two groups as far as normal daily consumed 
nutrients.  
 
Statistical Analysis 
Initial mean bone mass characteristics and descriptive statistics will be compared using 
unpaired student’s t-test. A paired samples t-test will be used to determine any differences 
between the pre and post total body and left and right hip BMD DEXA measurements for the 
entire groups. A multivariate ANOVA will then be then be used to determine if there were any 
significant group related differences for the DEXA scan results. Descriptive statistics, partial eta 
squared, and observed power will be determined by the multivariate ANOVA. A binomial 
regression will be used to determine the differences in the change score for the total body BMD. 
A bivariate correlation will be used to determine any significant correlations between data points. 
Lastly, the diet record data will be analyzed using an independent samples t-test to determine any 
differences between the two groups. Statistical analysis will be computed through computer 
programs available in the Statistical Package for the Social Sciences, version 12.0J (SPSS). The 
statistically significant level will be set at 0.05. 
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Results 
 
 
 No starting significant differences were found between the group of women in the 
placebo group (N=10) or the M. Oleifera group (N=9) in regards to body anthropometrics (Table 
1) for total subject anthropometric data. There was a very wide range in body fat percentages 
ranging from 8% up to 46% total body fat for the subject group at the start of the intervention. 
Subjects tended to be highly educated with only 4 of the 20 subjects not completing a graduate 
level degree. None of the subjects were currently smoking and the study participants averaged 
around 1-2 drinks per week. The two groups exercised slightly below 3-4 times a week on 
average with only one subject exercising less than 1 times per week.  
The daily medicines and vitamins and supplements were recorded and there were no 
notable differences in type or amount of consumed between the groups. The most common 
medicines taken were blood pressure medicines with only 6 subjects taking blood pressure 
medicine with 4 being from the M. Oleifera group and 2 being from the placebo group. The next 
most common drug recorded was for cholesterol. The vitamins and minerals were also recorded 
for this study. Both of these medicines were evenly distributed between the two subject groups. 
Nine out of the 19 women that finished the study took a daily multivitamin with that number 
being evenly split between M. Oleifera group (N=5) and the placebo group (N=4). Ten out of the 
19 women consumed a vitamin D supplement with 5 being from M. Oleifera and 5 from the 
placebo group (Table 2). 
No significant differences in starting height (p=.107), weight (p=.547), body fat 
percentage (p=.620), or lean mass (p=.857) were observed between the groups. There was also no 
significant changes throughout the intervention period for lean mass or body fat percentage 
(Figure 1 and 2). There also were no significant differences between the two group’s diets 
including average kcals, protein, carbohydrate, fat, sodium, potassium, vitamin D, vitamin C, 
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vitamin E, or vitamin A consumed (Table 3). There was however a moderate positive correlation 
(r=.550) between sodium intake and the pre BMD of the pelvis for the entire group (p=.015) 
which showed that higher sodium intakes in the diet correlate to higher BMD of the pelvis.  
Another moderate positive correlation (r=.499) was found between copper intake and post BMD 
of the Total Left Hip scan (p=.03) which showed that higher copper intakes correlate to higher 
BMD of the total left hip. There were some significant differences found in the before bone 
measurements between the two groups. Before the intervention was started the placebo group had 
a significantly higher BMD of the pelvis (p=.037) than the M. Oleifera group with the placebo 
group having a BMD of 1.18 g/cm² compared to 1.06 g/cm². There was also a significant 
difference between the groups when looking at the BMC (p=.042), BMD (p=.044), t-score 
(p=.044), and z-score (p=.049) of the total right hip before the intervention started with the 
placebo group having higher scores than the M. Oleifera group in all of the above areas. 
When looking at specific group differences for total body bone density there were no 
significant differences between the M. Oleifera group and the placebo group after the intervention 
period (Figure 3). There was no significant difference between the groups when the raw change 
score (-1 for percent decrease, 0 for no change, and +1 for increase) was computed for the total 
body BMD changes (p=.945). No significant difference between groups with the total left and 
right hip BMD measurements was found but there were small differences in the groups with the 
total right hip showed a .07% increase in the M. Oleifera group with a -.01% decrease in the 
placebo group (p=.168) (Figure 4). The M. Oleifera group had no change in the total left hip 
BMD while the placebo group had a -.02% decrease in the total hip BMD (p=.674) (Table 4). The 
only group related significant difference was found in the post pelvis BMD with the placebo 
group being significantly higher with 1.19 g/cm² than the M. Oleifera group with 1.04 g/cm² 
(p=.035), which is a factor seen in the pre-scan data as well. 
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When breaking down specific total group characteristics using an independent samples t-
test analysis there were significant differences found between the pre-total body BMD DEXA 
results and the post total body BMD DEXA results with the average for the entire subject group 
dropping from a BMD of 1.046 g/cm² to 1.034 g/cm² (p=.030) (Figure 1). A significant change in 
the difference between the pre-total body t-scores and the post-total body t-scores was seen with 
the whole subject group dropping from -.81 to -.97 (p=.019) (Figure 2). The group difference did 
not significantly affect the rate of bone loss however, with the M. Oleifera group losing 1.08% 
bone mass and the placebo group losing 1.14% bone mass of the total body BMD during the 12 
week period (p=.945). Also, a significant difference appeared when looking at the effect of 
exercise on total body BMD percent loss of the entire group. This result showed that the more 
times per week that a subject exercised the less bone density was lost (p=.044) (Figure 5). 
Significant negative correlations were seen with sodium (r=-.644; p=.003) and total body BMD 
percent change, as well (Figure 6). 
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Discussion 
Post-menopausal women consuming M. Oleifera for 12 weeks do not obtain any benefit 
in hip bone mineral density BMD or whole body BMD compared to those consuming placebo, in 
fact, analysis of both groups combined determined that BMD decreased significantly over the 12 
weeks. Specific analysis of the percent change from pre to post of these locations did not 
significantly differ between the two groups, even after accounting for the pre-scan bone density. 
Bone density of various regions did not significantly differ between M. Oleifera and placebo 
groups. The percent change of the total left and right hips for the entire subject group did not 
significantly vary from pre to post scans. Pelvic BMD was significantly different between groups 
prior to treatment and this difference persisted over the course of the study. Nutritional analysis 
revealed several significant correlations when measuring BMD at various sites with higher 
sodium and copper consumption positively correlating with BMD in the hip.   
To our knowledge, this is the first study in the United States to look at the effects of M. 
Oleifera on bone density and the first to ever record the dosage of M. Oleifera used during the 
study. Human studies experimenting with M. Oleifera have only so far focused on the anti-
lipidemic and -diabetic benefits of M. Oleifera (Arun Giridhari et al., 2011; Kumar Gupta et al., 
2013; Kumari, 2010; William et al., 1993). To date, only one other human study has examined 
the effects of M. Oleifera on bone properties, notably bone healing properties on jaw fractures. 
This particular study demonstrated that M. Oleifera intervention caused a decrease in swelling 
and tenderness and an increase in jaw mobility over the placebo group. However, this study did 
not focus on bone density specific BMD measurements using empirical methods but rather relied 
on the personal testimony of patients for assessing efficacy. Furthermore, this earlier study was 
not a blind study nor did it specify the specific dosage used (Singh et al., 2011). The design of the 
present study builds or improves upon this earlier or original study by measuring in a more 
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precise way: 1) bone density changes; 2) a specified dosage, and 3) was double blinded.  
The existing variability between subjects made teasing out statistically significant 
differences between the groups difficult, including determining whether the effects attributed to 
supplementation occurred. For this reason, Pearson’s correlation was also determined between 
groups and Cohen’s effect size was calculated. Furthermore, the researchers conducted a post-hoc 
G-Power analysis based on the determined power of the pre bone total bone density effects on the 
post scans. This analysis shows how the variability in subject group affects the ability to find 
significant results. Based on the number of subjects (N=19) and the observed variability between 
subjects, the minimum sample size needed for the present study should have been 3,930 subjects 
in order to have a power of 0.80. This shows the extreme variability of the total subject group that 
we had, as we had subjects range in body fat percentage from 8% to 46% in total and BMI from 
16.6 to 36. There were also people with osteopenia while there were others that were three 
standard deviations above normal BMD for their age. This variability drastically reduced the 
power and made this study unable to correctly determine the significant interactions M. Oleifera 
had on bone density. One reason that we were unable to determine the ideal sample size ahead of 
time is that there are currently no reported studies in the literature that have examined the effects 
of M. Oleifera on bone density in humans. This made the task of determining sample size and 
power very difficult. 
Despite the inability to determine differences between groups several important results 
were seen with the total population pre to post change. A significant interaction was found with 
the amount of exercise per week and the BMD change from pre to post. The more often exercise 
was performed per week the smaller the decrease in BMD; with even an increase in BMD in the 
highest exercise per week group. The importance of exercise on bone density is paramount since 
bone loading is essential in bone growth (Gregov & Šalaj, 2014; Kai, Anderson, & Lau, 2003). A 
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nutritional intervention, such as M. Oleifera, along with an exercise regimen may likely lead to an 
even more pronounced improvement in bone density outcomes.  
A second finding was the negative association of sodium intake and total body BMD 
changes. This relationship may exist due to poor diets that are high in sodium and low in essential 
vitamins and minerals. A diet that is predominantly fast food and pre-packaged tends to be higher 
in sodium and deficient in necessary vitamins and minerals. Research has shown that lower 
quality diets associate with lower BMD in an elderly population (Zeng et al., 2014). 
The most important and unexpected finding was that the total body bone density of all 
subjects drastically or acutely decreased over the 12 week time period. Normally, most post-
menopausal women lose up to 1% of their bone density during the whole year and not 12 weeks 
(Warming, Hassager, & Christiansen, 2002). Another earlier study found that women aged 80+ 
years lost 2.1 ± 0.7%/year, compared with 1.1 ± 0.2%/year among those aged 70–79 years and 
0.6 ± 0.1%/year among those aged 60–69 years (Nguyen, Sambrook, & Eisman, 1998). In our 
twelve-week time period the average bone loss was 1.11%, which is roughly a 4 times greater 
loss in total body BMD than previously reported. 
While the >1% drop in BMD in only 12 weeks is alarming, seasonal changes might 
account for the drop. Seasonal changes can drastically affect bone density (Rapuri, Kinyamu, 
Gallagher, & Haynatzka, 2002; Storm et al., 1998). It is important to note that the initial scans 
were conducted between August and September, while the post scans were performed during 
November and December. It is well known that during the summer months, bone density can 
increase due to increased sun exposure and more opportunities for out-door physical activity, 
while in contrast, during winter bone density decrease (Rapuri et al., 2002). Thus, BMD status 
between seasons overall fluctuates in a cyclical manner, with the total bone density returning to or 
slightly below baseline during the entire year. Rapuri et al. (2002) measured blood serum 
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25OHD, calcium, osteocalcin, and alkaline phosphates, as well as bone density for an entire year. 
The BMD of the spine (4.2%), total body (5%), and mid-radius (4.5%) was significantly higher in 
summer (June, July, August, and September) compared to winter (December, January, February, 
and March) (Rapuri et al., 2002). The fluctuation in serum levels of 25OHD also significantly 
correlated with bone density changes from summer to winter. It is likely that the seasonal timing 
of the present study may reflect the generated data and thus a lower bone density in the post-
scans.  
Secondly, in our health history questionnaire, we did not ask the subjects’ start of 
menopause age. It is well known that bone density will be lost at a higher rate in the first five 
years after menopause  (Harris & Dawson-Hughes, 1992; Pouilles, Tremollieres, & Ribot, 1995). 
BMD rate of change 1-2 years after menopause can be as high as −2.24%/ year, but this rate of 
loss slows after 6 or more years after menopause and the rate of loss is around 1% (Harris & 
Dawson-Hughes, 1992). In the current study, subjects were between the ages of 60 and 70. With 
the average of menopause at 51, some women may not have reached menopause until age 55-57 
(Daan & Fauser, 2015). Therefore the possibility exists that subjects were still in the more rapid 
bone loss stage of the first few years immediately after menopause.  
Lastly, certain medications affect BMD. High blood pressure seems to be associated with 
lower BMD in elderly white women (Cappuccio, Meilahn, Zmuda, & Cauley, 1999). This study 
found that between the first and fourth quartile hypertensive medication taken, bone density 
dropped between 0.34% and 0.59% over a three-year period. A significant correlation in bone 
density and diastolic blood pressure was also observed in women under 70 years of age 
(Cappuccio et al., 1999). Although we did not specifically measure blood pressure, six of the 19 
subjects studied were taking prescription blood pressure medications. Also, selective serotonin 
reuptake inhibitors (SSRI’s), such as Lexapro or Prozac, tend to associate with lower BMD in 
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postmenopausal women (Diem et al., 2007). Bone density dropped 0.47% in non-SSRI users 
while in women who took SSRIs it dropped an average of 0.82% per year in one study (Diem et 
al., 2007). Six women took various SSRI’s in this study. All of these related medical factors 
might contribute to the large percentage decrease seen in total body bone density.  
A twelve week bone density intervention is around the minimum time required to observe 
bone density changes (Gregov & Šalaj, 2014), which is why the current duration was selected in 
the present study. Although the present study was unable to demonstrate a difference in bone 
density between the M. Oleifera and the placebo groups during the 12-week time frame, it is 
likely that with a longer-term supplementation period, significant changes could be seen. Despite 
the lack of bone density changes there may have been hormonal or molecular changes in this time 
period. Without taking blood samples, however, it is impossible to conclude that any significant 
molecular or hormonal changes took place due to M. Oleifera. 
 Secondly, the amount of M. Oleifera might not have been high enough to have 
measurable effects on BMD in only 12 weeks. It is important to mention that this is the first 
systematic study that examined the effects of M. Oleifera on bone density and provided the exact 
dosage and duration in humans. The lack of well-established prior dosage recommendations did 
not make it easy in designing the present study and may in part explain the lack of difference of 
statistical significance between the two groups (Estrella et al., 2000; Singh et al., 2011). Animal 
studies have used a wide range of M. Oleifera dosage, which overall is between 4mg/kg and 
300mg/kg (Chen et al., 2012; Jaiswal et al., 2009; Nandave et al., 2009). However, these studies 
mostly used an aqueous form of M. Oleifera, rather than the whole leaf powder used in the 
present study. Another article using an avian animal model (chicken) and looking at the effects of 
M. Oleifera on bone strength used up to 25g of M. Oleifera per kg of chicken feed (Nkukwana et 
al., 2014). However, these animal models were not similar enough to humans to draw any useful 
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insights in determining specific appropriate dosage for human studies. In the absence of 
meaningful animal models or human studies, we reasoned that a one gram dosage might be 
enough to elicit changes, while ensuring safety (Asare et al., 2012). 
Future studies exploring M. Oleifera’s health effects could measure blood samples to 
determine the potential interaction between M. Oleifera and hormones, such as estrogen or 
progesterone. Secondly, a blood sample potentially could show other benefits of M. Oleifera, 
such as its anti-hypertensive, anti-dislipidemic, anti-oxidant, and cardio-protective properties. 
Also future studies can use the data found in this study to better predict the sample size needed to 
find statistical differences. Thirdly, additional use of a peripheral CT scanner, which is a more 
sensitive tool, could be used to determine more specific and subtle bone changes. Fourthly, we 
suggest that the length of the study in future should be further extended by at least six months in 
order to show whether M. Oleifera has any measurable effects in the long term. Lastly, the effects 
of combined exercise and nutrition (M. Oleifera) on bone density could be further explored by 
separating the subjects into more groups, such as a control group, an exercise group, an exercise 
plus M. Oleifera group, and a M. Oleifera only group. This could ensure that the benefits of M. 
Oleifera are delineated from those of exercise on bone density. 
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Conclusion 
 
In conclusion, no evidence exists in short term supplementation of M. Oleifera on BMD 
of post-menopausal women. The most significant finding was the overall loss in total body bone 
density in the complete subject group. This loss may be due to a variety of factors, such as normal 
seasonal changes, higher initial bone densities, intake of medications, or others. Future studies 
can use data from the present study as a base to further our understanding and expand our 
research knowledge about effective nutritional options that can help reduce bone density. Future 
studies should use a larger sample size, increase the length of the intervention, take blood samples 
to examine interaction with hormones and levels of blood vitamin levels, and control more for 
exercise, diet and medication interactions.  
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TABLES 
 
Subject: Group Age Height (cm) Weight (kg) BMI % Body Fat 
1 A 63 179.07 72.12 22.51 29.9 
2 A 66 170.18 52.16 18 15.9 
3 B 63 152.4 50.35 21.64 30.3 
4 B 65 163.83 90.72 33.46 45.9 
5 A 64 170.18 72.57 25.09 34.9 
6 B 62 158.75 57.15 22.55 31.2 
7 A 63 170.18 60.33 20.88 32.5 
8 A 67 176.53 90.72 29.29 46.6 
9 B 60 172.72 65.77 22 32.6 
10 A 60 165.1 71.21 26.16 39.1 
11 A 64 165.1 70.76 25.99 40.5 
12 B 66 157.48 61.24 24.84 37.3 
13 B 68 167.64 92.87 33 39.9 
14 B 67 167.64 63.5 22.5 32.9 
15 B 63 175.56 108.86 35.27 42 
16 B 68 158.75 56.69 22.86 26.2 
17 A 64 167.64 46.72 16.6 7.96 
18 B 64 165.1 68.04 24.98 30.3 
19 A 63 160.02 72.57 28.35 42.2 
20 A 68 165.1 61.68 22.77 37.4 
Averages 65.615789 164.23395 70.498105 26.042263 34.430737 
Std. Deviations 2.4365636 6.8098437 15.884186 4.9085351 9.4058658 
 
Table 1. Post-menopausal women anthropometric data for subjects at the pre scan time period. 
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Subject: Group Medications Supplements 
1 A 
Depression (Buproprion), Pain 
(Aspirin, Naproxin) 
Super B & Vit C (150mcg), Biotin (5000mg), D3 
(5000IU) 
2 A Thyroid (levothyroxine) Multivitamin, Vit D3 (1000 IU), Fish Oil 1200mg 
3 B 
Cholesterol (Simvastatin), Arthritis 
(Ibuprofen),  
Depression (Wellbutrin), Allergy D3 (5000mg) 
4 B 
Blood Pressure (Lisinopril), 
Cholesterol (Simastatin),  
Diabetes (Metformin, Gupizide) Multivitamin, D3 (5000IU), Magnesium Citrate (100mg),  
5 A 
Blood Pressure (Norvasc), Allergy 
(Flonase) 
One A Day Womens, B Complex, Biotin (1000 mg), Co-
Q-10 (100mg), Niacin (400mg), Magnesium (400mg), 
Calcium w/ Vit D (1200mg Ca, 1000mg D) 
6 B  
One A Day Womens, D3 (100mg), B6 (2000IU), Fish Oil 
(1000mg), Throid Complex (Mg, Cu, Zn, B12 (100mcg), 
Tyrosine), Selenium (200mcg), Lutein (20mg) 
7 A  B Total Multivitamin, Opticon 
8 A 
Blood Pressure (Clonidine), Anxiety 
(Fluoxetine), Allergy (Fluticasone) Vit D (2000mg) 
9 B 
Anxiety (Occasional Clonazapam), 
Hormone Based Chemotherapy 
(Anastrazole) Multivitamin, Calcium, Magnesium (No mg given) 
10 A 
Blood Pressure (HTZ), Cholesterol 
(Atorvastatin), 
Depression (Escitalopram), Thyroid 
(Levothyroxine), Allergy 
(Hydroxyzine)  
11 A  Multivitamin, Calcium, Magnesium (No mg given) 
12 B 
Depression (Lexapro), Allergy 
(Loratadine) Calcium w/ Vit D (600mg) 
13 B 
Blood Pressure (Lisinopril), 
Cholesterol (Pravastatin),  
Depression (Fluoxentine), Throid 
(Levothyroxine), Allergy (Zertec) Vit C (500mg), Zinc (50mg), Fish Oil (2000mg) 
14 B   
15 B 
Blood Pressure (Diovan), Athritis 
(Naproxen), Weight Loss (contrave)  
16 B ADD (Strattera), Pain (Aspirin) Vit C (1000mg), Biotin, Citracal 
17 A Depression (Prozac), Anxiety (Buspar)  
18 B Ulcer (Omeprazole) 
Equate Womens Vitamin, D3 (250IU), Calcium Citrate 
(315mg), Fish Oil (1200mg), Glucosamine 
19 A Allergy (Cetirizine) B-12 (100mg) 
20 A  
Reliv Supplement (Vit D (400), Vit C (480mg), Vit A 
(2500IU), Calcium (1000mg), Iron (10mg) 
 
Table 2. Post-menopausal women medicines and supplements taken by individual as seen by 
Health History Questionnaire 
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Subje
ct: 
Grou
p: 
Total 
Kcal 
Pro
tein 
(g) 
Carb 
(g) 
Fat 
(% of 
calori
es) 
Vita
min 
C 
(mg) 
Vita
min 
E 
(mg) 
Vit D 
(ug) 
Vit A 
(ug) 
Selen
ium 
(ug) 
Iron 
(mg) 
Zinc 
(mg) 
Copp
er 
(ug) 
Mag
nesiu
m 
(mg) 
Sodi
um 
(mg) 
Potas
sium 
(mg) 
1 A 1470 69 153 35% 65 12 3 1250 87 16 10 1531 319 3203 2487 
2 A 911 42 127 29% 54 4 11 1064 48 11 4 652 186 1722 1902 
3 B 1525 40 241 24% 135 7 3 1474 73 12 6 1147 231 2128 2837 
4 B 1292 89 104 42% 94 7 4 900 127 9 10 1344 300 1139 2649 
5 A 2190 94 350 21% 135 50 4 847 61 17 20 3330 627 1880 3878 
6 B 1790 81 163 38% 85 13 3 503 109 9 109 1231 343 1768 2823 
7 A 1842 64 242 34% 111 6 1 2219 92 14 8 1435 235 3065 2795 
8 A 1406 88 161 28% 23 4 2 1151 115 12 9 973 258 2516 2146 
9 B 1297 46 126 48% 12 4 1 262 84 9 7 720 137 2614 1113 
10 A 1678 78 192 31% 116 4 2 592 75 17 11 1057 247 2694 2640 
11 A 2000 69 249 37% 40 8 1 232 96 15 9 1142 239 3238 2063 
12 B 1718 98 205 31% 153 9 13 545 105 9 11 1525 309 2048 2919 
13 B 1501 57 179 38% 40 3 1 720 93 14 8 1083 178 3005 1773 
14 B 1314 52 174 33% 77 10 2 940 61 13 9 1382 243 2596 2490 
15 B 1243 82 78 50% 205 5 2 626 86 9 10 781 198 2933 2319 
16 B 2041 98 204 38% 141 25 2 509 98 13 11 1572 481 2915 3012 
17 A 1324 93 133 35% 93 12 3 570 81 7 7 1051 297 869 3012 
18 B 1535 70 165 37% 94 8 8 1053 86 12 10 1144 290 2156 2895 
20 A 1186 57 118 42% 80 11 1   504 68 10 8 1430 377 1773 2046 
Averages 
1540.1 
71.
9 177.1 
35.3
% 92.3 10.6 3.5 840.1 86.6 12 14.6 
1291.
1 289.2 
2329.
6 
2515.
7 
Std. 
Deviations 319.7 
18.
6 61.6 
0.07
% 47.4 10.6 3.4 458.8 19.3 2.9 22.5 548.7 110.3 669.2 583.2 
 
Table 3. Post-menopausal women diet record three day averages for each individual as interpreted 
by USDA Super Tracker online.   
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Table 4. Post-menopausal women percent changes for average Total Body, Left Hip, and Left hip 
BMD between the pre and post time periods. Result showing significance level, effect size and 
power of sample. 
 
 
 
 
 
 
 
 
 
 
 
 
Group 
Avg. % Change -
Total Body 
Standard 
Deviation p value 
Effect 
size Power 
M. 
Oleifera 
-1.08 2.58 
0.945 0.000 0.052 
Placebo -1.14 1.62       
  
Avg. % Change - 
Total Left Hip         
M. 
Oleifera 
0.00 0.12 
0.674 0.011 0.069 
Placebo -0.02 0.07       
  
Avg. % Change - 
Total Right Hip         
M. 
Oleifera 
0.07 0.17 
0.168 0.109 0.275 
Placebo -0.01 0.04       
   
 
56 
 
 
Vita 
 
 
Jason Michael Brown was born in Hamilton, Ohio to Dr. Tim and Vivian Brown. He 
graduated from Cincinnati Christian High School in 2009. The next fall he entered Furman 
University and studied Health and Exercise Science. In August 2013 he was awarded the 
Bachelor of Science degree. In the fall of 2014 he accepted a research assistantship in Exercise 
Science at Appalachian State University and began study towards a Master of Science degree.  
 
 
 
 
